Medizinische Klinik (Munich, Germany : 1983) · 2004
[Interactions of statins with antithrombotic drugs].
Сравнительное исследованиеСтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ruef Johannes
Аннотация
Due to a wealth of scientific clinical data, statins are being extensively used for the primary and secondary prevention of ischemic events. Therefore, statins play a major part in the pharmacological treatment of cardiovascular disease. Even before it became apparent that statins are effective despite normal baseline lipid levels, it was known that statins exert additional effects on the vascular wall that are independent of lipid lowering and protective toward the arteriosclerotic plaque. Some of these pleiotropic effects are related to hemostasis: through profibrinolytic, antiadhesive and antiaggregatory mechanisms, statins act antithrombotic. Based on experimental results, concerns were brought forward Simthat atorvastatin interferes with the antithrombotic effects of the ADP-receptor inhibitor prodrug, clopidogrel, due to competitive affinity to liver enzymes. So far, however, other experimental as well as clinical data do not support the hypothesis that atorvastatin or any other statin affects the antithrombotic potency of clopidogrel. The aforementioned issues will be discussed.
Предметные рубрики MeSH
AnimalsAnticholesteremic AgentsAspirinAtorvastatinCardiovascular DiseasesClopidogrelControlled Clinical Trials as TopicDrug InteractionsDrug Therapy, CombinationFibrinolytic AgentsFollow-Up StudiesHemostasisHeptanoic AcidsHumansHydroxymethylglutaryl-CoA Reductase InhibitorsPlatelet Aggregation InhibitorsPravastatinPrimary PreventionPyrrolesRatsTiclopidineTime Factors